Interrogation of requisite niche factors for leukemia cell survival at single-cell resolution
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110283
- Recipient
-
Massachusetts Institute Of Technology UEI E2NYLCDML6V1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $619,846
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
About this award
The Massachusetts Institute of Technology (MIT) received a $619,846 Project Grant award from the Department of the Army Medical Command through the Military Medical Research and Development program (CFDA 12.420). The two-year project, beginning June 1, 2021 and concluding May 31, 2023, will support research to interrogate requisite niche factors for leukemia cell survival at single-cell resolution. Through this funding, MIT researchers will investigate medical solutions for the battlefield by transforming health care for service members and the public through innovative and impactful biomedical research. The grant will enable MIT to conduct basic, applied, and advanced research to better understand leukemia cell survival mechanisms at the single cell level, with the goal of developing new treatment approaches for blood cancers.
Quick answers
Who received award W81XWH2110283?
W81XWH2110283 was awarded to Massachusetts Institute Of Technology by Medical Command (Department of the Army) on June 1, 2021.
How much is award W81XWH2110283 worth?
$619,846 has been obligated on W81XWH2110283.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award